ConductScience.org, home

Paper20002783

Lopinavir protein binding in HIV-1-infected pregnant women.

Aweeka FT and 10 others. HIV Med, 2010. Cited by 39 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Lopinavir protein binding in HIV-1-infected pregnant women. Papers, record 20002783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20002783

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lopinavir protein binding in HIV-1-infected pregnant women.
PubMed
Journal
HIV Med
PubMed
Year
2010
PubMed
Publication types
Journal Article, Multicenter Study, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
1.4
iCite
Revised in PubMed
2026-05-18
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aweeka FTF T
2Stek AA
3Best BMB M
4Hu CC
5Holland DD
6Hermes AA
7Burchett SKS K
8Read JJ
9Mirochnick MM
10Capparelli EVE V
11International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1026s Protocol TeamGroup

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acute-Phase ProteinsMajor topic
HIV InfectionsMajor topic
HIV Protease InhibitorsMajor topic
HIV-1Major topic
Pregnancy Complications, InfectiousMajor topic
PyrimidinonesMajor topic
Adolescent
Adult
Antiretroviral Therapy, Highly Active
Drug Therapy, Combination
Female
Humans
Lopinavir
Pregnancy
Pregnancy Trimester, Third
Prospective Studies
Protein Binding
Ritonavir
Young Adult

Source PubMed

Grants13

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01-HD-031318-11NICHD NIH HHSUnited StatesU01HD031318PubMed and NIHNIH RePORTER
U01 AI068632NIAID NIH HHSUnited StatesU01AI068632PubMed and NIHNIH RePORTER
M01 RR000533NCRR NIH HHSUnited StatesM01RR000533PubMed and NIHNIH RePORTER
U01 HD031318NICHD NIH HHSUnited StatesU01HD031318PubMed and NIHNIH RePORTER
M01 RR001271NCRR NIH HHSUnited StatesM01RR001271PubMed and NIHNIH RePORTER
UM1 AI069477NIAID NIH HHSUnited StatesU01AI069477PubMed and NIHNIH RePORTER
U01 AI068616NIAID NIH HHSUnited StatesU01AI068616PubMed and NIHNIH RePORTER
M01 RR00533NCRR NIH HHSUnited StatesM01RR000533PubMed and NIHNIH RePORTER
U01AI068632NIAID NIH HHSUnited StatesU01AI068632PubMed and NIHNIH RePORTER
5 M01 RR01271NCRR NIH HHSUnited StatesM01RR001271PubMed and NIHNIH RePORTER
1 U01 AI068616NIAID NIH HHSUnited StatesU01AI068616PubMed and NIHNIH RePORTER
N01-HD-3-3365NICHD NIH HHSUnited StatesPubMedPubMed
UM1AI069477NIHNIH RePORTER

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00042289Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After PregnancyResults

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16,749,369Plasma protein binding of drugs in pregnancy.Clin Pharmacokinet1982https://conductscience.org/library/papers/6749369PubMed
26,600,623Serum protein pattern in normal pregnancy with special reference to acute-phase reactants.Br J Obstet Gynaecol1983https://conductscience.org/library/papers/6600623PubMed
37,413,726Drug disposition and pharmacokinetics in the maternal-placental-fetal unit.Pharmacol Ther1980https://conductscience.org/library/papers/7413726PubMed
418,989,231Lopinavir exposure with an increased dose during pregnancy.J Acquir Immune Defic Syndr2008https://conductscience.org/library/papers/18989231PubMed
519,439,488Binding of lopinavir to human alpha1-acid glycoprotein and serum albumin.Drug Metab Dispos2009https://conductscience.org/library/papers/19439488PubMed
616,880,170HIV pharmacology: barriers to the eradication of HIV from the CNS.HIV Clin Trials2006https://conductscience.org/library/papers/16880170PubMed
716,420,257Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.HIV Med2006https://conductscience.org/library/papers/16420257PubMed
82,178,848Plasma protein binding of drugs in pregnancy and in neonates.Clin Pharmacokinet1990https://conductscience.org/library/papers/2178848PubMed
97,471,620Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.Clin Pharmacol Ther1981https://conductscience.org/library/papers/7471620PubMed
1016,954,724The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.AIDS2006https://conductscience.org/library/papers/16954724PubMed
1116,330,496Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain.J Pharmacol Exp Ther2006https://conductscience.org/library/papers/16330496PubMed
126,538,287Renal function and therapeutic concentrations of phenytoin.Neurology1984https://conductscience.org/library/papers/6538287PubMed
1316,988,514Reduced lopinavir exposure during pregnancy.AIDS2006https://conductscience.org/library/papers/16988514PubMed
1415,696,014Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy.Am J Obstet Gynecol2005https://conductscience.org/library/papers/15696014PubMed

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
40,323,543
Maternal-Fetal Physiologically Based Population Pharmacokinetics Model Development of Lopinavir/Ritonavir in HIV/HBV Co-infected Pregnant Women to Quantitatively Describe the Gestational PK Characteristics and Predict the Potential Disease-Drug-Drug Interaction (DDDI).
Clin Pharmacokinet2025https://conductscience.org/library/papers/40323543PubMed
36,916,944Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention.Antimicrob Agents Chemother2023https://conductscience.org/library/papers/36916944PubMed
34,722,417Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development.Front Pediatr2021https://conductscience.org/library/papers/34722417PubMed
32,798,276Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy.J Clin Pharmacol2020https://conductscience.org/library/papers/32798276PubMed
28,391,404Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.Clin Pharmacokinet2017https://conductscience.org/library/papers/28391404PubMed
27,802,281Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review.PLoS Med2016https://conductscience.org/library/papers/27802281PubMed
27,069,778Model-Based Analysis of Unbound Lopinavir Pharmacokinetics in HIV-Infected Pregnant Women Supports Standard Dosing in the Third Trimester.CPT Pharmacometrics Syst Pharmacol2016https://conductscience.org/library/papers/27069778PubMed
26,878,071PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150.Jacobs J AIDS HIV2015https://conductscience.org/library/papers/26878071PubMed
26,525,798No Need for Lopinavir Dose Adjustment during Pregnancy: a Population Pharmacokinetic and Exposure-Response Analysis in Pregnant and Nonpregnant HIV-Infected Subjects.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/26525798PubMed
26,149,996Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26149996PubMed
25,950,206Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.J Acquir Immune Defic Syndr2015https://conductscience.org/library/papers/25950206PubMed
25,407,158Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.HIV Med2015https://conductscience.org/library/papers/25407158PubMed
24,038,035Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda.J Clin Pharmacol2014https://conductscience.org/library/papers/24038035PubMed
23,335,197Etravirine in CSF is highly protein bound.J Antimicrob Chemother2013https://conductscience.org/library/papers/23335197PubMed
23,274,970Interpreting tacrolimus concentrations during pregnancy and postpartum.Transplantation2013https://conductscience.org/library/papers/23274970PubMed
23,221,983Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelines.J Acquir Immune Defic Syndr2013https://conductscience.org/library/papers/23221983PubMed
23,018,528Pharmacokinetic optimization of antiretroviral therapy in pregnancy.Clin Pharmacokinet2012https://conductscience.org/library/papers/23018528PubMed
22,852,073Global HIV/AIDS Clinical and Translational Pharmacology.AIDS Res Treat2012https://conductscience.org/library/papers/22852073PubMed
22,106,215Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22106215PubMed
20,625,263Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy.AIDS2010https://conductscience.org/library/papers/20625263PubMed

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15,243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CYP3A41,576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene

Drugs40

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
AMPRENAVIRCHEMBL116Results1https://conductscience.org/library/drugs/CHEMBL116ChEMBL
ATAZANAVIRCHEMBL1163Results1https://conductscience.org/library/drugs/CHEMBL1163ChEMBL
AMINOSALICYLIC ACIDCHEMBL1169Results1https://conductscience.org/library/drugs/CHEMBL1169ChEMBL
DOLUTEGRAVIRCHEMBL1229211Results1https://conductscience.org/library/drugs/CHEMBL1229211ChEMBL
LINEZOLIDCHEMBL126Results1https://conductscience.org/library/drugs/CHEMBL126ChEMBL
DARUNAVIRCHEMBL1323Results1https://conductscience.org/library/drugs/CHEMBL1323ChEMBL
ABACAVIRCHEMBL1380Results1https://conductscience.org/library/drugs/CHEMBL1380ChEMBL
KANAMYCINCHEMBL1384Results1https://conductscience.org/library/drugs/CHEMBL1384ChEMBL
ETHIONAMIDECHEMBL1441Results1https://conductscience.org/library/drugs/CHEMBL1441ChEMBL
DIDANOSINECHEMBL1460Results1https://conductscience.org/library/drugs/CHEMBL1460ChEMBL
ETONOGESTRELCHEMBL1531Results1https://conductscience.org/library/drugs/CHEMBL1531ChEMBL
EMTRICITABINE, (+/-)-CHEMBL161381Results1https://conductscience.org/library/drugs/CHEMBL161381ChEMBL
FOSAMPRENAVIRCHEMBL1664Results1https://conductscience.org/library/drugs/CHEMBL1664ChEMBL
RILPIVIRINECHEMBL175691Results1https://conductscience.org/library/drugs/CHEMBL175691ChEMBL
AMIKACINCHEMBL177Results1https://conductscience.org/library/drugs/CHEMBL177ChEMBL
COBICISTATCHEMBL2095208Results1https://conductscience.org/library/drugs/CHEMBL2095208ChEMBL
TERIZIDONECHEMBL2107553Results1https://conductscience.org/library/drugs/CHEMBL2107553ChEMBL
DELAMANIDCHEMBL218650Results1https://conductscience.org/library/drugs/CHEMBL218650ChEMBL
CAPREOMYCINCHEMBL2221250Results1https://conductscience.org/library/drugs/CHEMBL2221250ChEMBL
TIPRANAVIRCHEMBL222559Results1https://conductscience.org/library/drugs/CHEMBL222559ChEMBL

See all 40 drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20002783

GET https://conductscience.org/api/papers/v1/20002783/drugs?page=2